Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors
Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors – Licensing opportunity (PDF)
Explore other Stories:
Knowledge Bites: Intellectual property and patenting
Why is intellectual property important? What is included in intellectual property and what not? How does patenting work? Sanne Stembert of IXA explains everything you need to know about the valorisation process, intellectual property and patenting.
Story Talk: How to build a diverse and inclusive start-up
How is diversity and inclusivity relevant for start-ups? And what can you do as a start-up to contribute to these themes? IXA sits down with Michael Musandu and Bouchra Talidi to talk about the benefits of building a diverse and inclusive start-up and to receive some tips on how to do so.
An idea leads to a research project for which an instrumental set-up is needed
AMC clinical physiologist Peter Sterk’s idea to explore the use of e-nose technology for diagnosis of lung disease has really payed off. His brand-new ‘SpiroNose’ breath analyser will shortly become available for hospitals and general practices. Sterk is confident about the clinical validation studies that are now underway: “The SpiroNose will be a formidable addition […]